150 related articles for article (PubMed ID: 10092986)
21. Synergistic effects of tumour necrosis factor and morphine on gut barrier function.
Leslie KA; Behme R; Clift A; Martin S; Grant D; Duff JH
Can J Surg; 1994 Apr; 37(2):143-7. PubMed ID: 8156468
[TBL] [Abstract][Full Text] [Related]
22. Interdigestive and postprandial motility in small-intestinal bacterial overgrowth.
Stotzer PO; Björnsson ES; Abrahamsson H
Scand J Gastroenterol; 1996 Sep; 31(9):875-80. PubMed ID: 8888434
[TBL] [Abstract][Full Text] [Related]
23. Differential regional effects of octreotide on human gastrointestinal motor function.
von der Ohe MR; Camilleri M; Thomforde GM; Klee GG
Gut; 1995 May; 36(5):743-8. PubMed ID: 7797125
[TBL] [Abstract][Full Text] [Related]
24. Octreotide inhibits hepatic fibrosis, bile duct proliferation and bacterial translocation in obstructive jaundice.
Türkçapar N; Bayar S; Koyuncu A; Ceyhan K
Hepatogastroenterology; 2003; 50(51):680-3. PubMed ID: 12828059
[TBL] [Abstract][Full Text] [Related]
25. Effect of morphine sulfate on intestinal transit and myoelectric activity of the small intestine of the rat.
Weisbrodt NW; Sussman SS; Stewart JJ; Burks TF
J Pharmacol Exp Ther; 1980 Aug; 214(2):333-8. PubMed ID: 7391981
[TBL] [Abstract][Full Text] [Related]
26. Role of intestinal bacterial overgrowth and intestinal motility in bacterial translocation in experimental cirrhosis.
Sánchez E; Casafont F; Guerra A; de Benito I; Pons-Romero F
Rev Esp Enferm Dig; 2005 Nov; 97(11):805-14. PubMed ID: 16438624
[TBL] [Abstract][Full Text] [Related]
27. A prospective, double-blind trial of somatostatin analog (octreotide) versus glucagon for the inhibition of small intestinal motility during endoscopic retrograde cholangiopancreatography.
Van Dam J; Catalano MF; Ferguson DR; Barnes DS; Zuccaro G; Sivak MV
Gastrointest Endosc; 1995 Oct; 42(4):321-4. PubMed ID: 8536900
[TBL] [Abstract][Full Text] [Related]
28. Relationship between dietary-induced changes in intestinal commensal microflora and duodenojejunal myoelectric activity monitored by radiotelemetry in the rat in vivo.
Lesniewska V; Rowland I; Laerke HN; Grant G; Naughton PJ
Exp Physiol; 2006 Jan; 91(1):229-37. PubMed ID: 16263800
[TBL] [Abstract][Full Text] [Related]
29. Cisapride prevents enteric bacterial overgrowth and translocation by improvement of intestinal motility in rats with acute liver failure.
Wang XD; Soltesz V; Andersson R
Eur Surg Res; 1996; 28(6):402-12. PubMed ID: 8954316
[TBL] [Abstract][Full Text] [Related]
30. The effect of octreotid on bacterial translocation from the gut. An experimental study.
Türkçapar AG; Ersöz S; Gür U; Yerdel MA; Karaaslan A; Erden E; Kuterdem E
Int Surg; 1995; 80(3):264-6. PubMed ID: 8775617
[TBL] [Abstract][Full Text] [Related]
31. Lubiprostone Accelerates Intestinal Transit and Alleviates Small Intestinal Bacterial Overgrowth in Patients With Chronic Constipation.
Sarosiek I; Bashashati M; Alvarez A; Hall M; Shankar N; Gomez Y; McCallum RW; Sarosiek J
Am J Med Sci; 2016 Sep; 352(3):231-8. PubMed ID: 27650225
[TBL] [Abstract][Full Text] [Related]
32. Alterations in intestinal motility and microflora in experimental acute pancreatitis.
Leveau P; Wang X; Soltesz V; Ihse I; Andersson R
Int J Pancreatol; 1996 Oct; 20(2):119-25. PubMed ID: 8968867
[TBL] [Abstract][Full Text] [Related]
33. Morphine inhibits gastrointestinal transit in the rat primarily by impairing propulsive activity of the small intestine.
Fiocchi R; Bianchi G; Petrillo P; Tavani A; Manara L
Life Sci; 1982 Nov 15-22; 31(20-21):2221-3. PubMed ID: 7162339
[TBL] [Abstract][Full Text] [Related]
34. The influence of somatostatin on bacterial translocation.
Tocchi A; Costa G; Lepre L; Mazzoni G; Liotta G; Agostini N; Miccini M; Cassini D
Panminerva Med; 2001 Mar; 43(1):11-4. PubMed ID: 11319512
[TBL] [Abstract][Full Text] [Related]
35. Small Intestinal Transit Time Is Delayed in Small Intestinal Bacterial Overgrowth.
Roland BC; Ciarleglio MM; Clarke JO; Semler JR; Tomakin E; Mullin GE; Pasricha PJ
J Clin Gastroenterol; 2015 Aug; 49(7):571-6. PubMed ID: 25319735
[TBL] [Abstract][Full Text] [Related]
36. Effects of somatostatin analogues and vitamin C on bacterial translocation in an experimental intestinal obstruction model of rats.
Akyildiz M; Ersin S; Oymaci E; Dayangaç M; Kapkac M; Alkanat M
J Invest Surg; 2000; 13(3):169-73. PubMed ID: 10933113
[TBL] [Abstract][Full Text] [Related]
37. Octreotide does not prevent bacterial translocation in an infant piglet model of intestinal ischemia-reperfusion.
Taylor GE; Hebra A; McGowan KL; Yu M; Myers S; McKernan ML; Boardman C; Ross AJ; O'Neill JA
J Pediatr Surg; 1995 Jul; 30(7):967-9; discussion 969-70. PubMed ID: 7472954
[TBL] [Abstract][Full Text] [Related]
38. Octreotide inhibition of flushing and colonic motor dysfunction in carcinoid syndrome.
Saslow SB; O'Brien MD; Camilleri M; von der Ohe M; Homburger HA; Klee GG; Pitot HC; Rubin J
Am J Gastroenterol; 1997 Dec; 92(12):2250-6. PubMed ID: 9399764
[TBL] [Abstract][Full Text] [Related]
39. The association between enteric bacterial overgrowth and gastrointestinal motility after subtotal liver resection or portal vein obstruction in rats.
Wang XD; Guo WD; Wang Q; Andersson R; Ekblad E; Soltesz V; Bengmark S
Eur J Surg; 1994 Mar; 160(3):153-60. PubMed ID: 7516192
[TBL] [Abstract][Full Text] [Related]
40. [Effect of interstitial cells of Cajal on gastrointestinal motility induced by motilin receptor agonist ABT-229].
Wang CH; Wang LC; Jiang X; Lan L; Liu L; Sun Y; Wang BX
Zhonghua Er Ke Za Zhi; 2010 Apr; 48(4):254-9. PubMed ID: 20654011
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
